SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vladimir G. Budker, Sean D. Monahan, Vladimir M. Subbotin, Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction, Drug Discovery Today, 2014, 19, 12, 1855

    CrossRef

  2. 2
    P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal, Management of hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2014,

    CrossRef

  3. 3
    D.-H. Kim, T. Choy, S. Huang, R.M. Green, R.A. Omary, A.C. Larson, Microfluidic fabrication of 6-methoxyethylamino numonafide-eluting magnetic microspheres, Acta Biomaterialia, 2014, 10, 2, 742

    CrossRef

  4. 4
    Liang Shi, Yili Feng, Hui Lin, Rui Ma, Xiujun Cai, Role of estrogen in hepatocellular carcinoma: is inflammation the key?, Journal of Translational Medicine, 2014, 12, 1, 93

    CrossRef

  5. 5
    Ahmed Abdelmabood Zeeneldin, Salem Mohamed Eid, Amira Diaa Darweesh, Manar Mohamed Moneer, Mohamed Saadeldin, Tamoxifen compared to best supportive care in advanced hepatocelluar carcinoma: A retrospective matched-cohort study, Journal of the Egyptian National Cancer Institute, 2014, 26, 1, 1

    CrossRef

  6. 6
    Daniel Johnson, Treatment of Cancer Sixth Edition, 2014,

    CrossRef

  7. 7
    Marcello Maida, Giuseppe Cabibbo, Giuseppe Brancatelli, Chiara Genco, Nicola Alessi, Claudio Genova, Piero Romano, Maurizio Raineri, Antonello Giarratano, Massimo Midiri, Calogero Cammà, Assessment of treatment response in hepatocellular carcinoma: a review of the literature, Future Oncology, 2013, 9, 6, 845

    CrossRef

  8. 8
    Nicole H.Y. Kong, Pierce K.H. Chow, Conducting randomised controlled trials across countries with disparate levels of socio-economic development: The experience of the Asia-Pacific Hepatocellular Carcinoma Trials Group, Contemporary Clinical Trials, 2013, 36, 2, 682

    CrossRef

  9. 9
    Vahid Yaghmai, Cecilia Besa, Edward Kim, Joseph L. Gatlin, Nasir A. Siddiqui, Bachir Taouli, Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy, American Journal of Roentgenology, 2013, 201, 1, 80

    CrossRef

  10. 10
    Yao-Tsung Yeh, Chien-Wei Chang, Ren-Jie Wei, Shen-Nien Wang, Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects, BioMed Research International, 2013, 2013, 1

    CrossRef

  11. 11
    EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma, European Journal of Cancer, 2012, 48, 5, 599

    CrossRef

  12. 12
    P K H Chow, D Machin, Y Chen, X Zhang, K-M Win, H-H Hoang, B-D Nguyen, M-Y Jin, R Lobo, M Findlay, C-H Lim, S-B Tan, M Gandhi, K-C Soo, Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma, British Journal of Cancer, 2011, 105, 7, 945

    CrossRef

  13. 13
    Stephen H. Wrzesinski, Tamar H. Taddei, Mario Strazzabosco, Systemic Therapy in Hepatocellular Carcinoma, Clinics in Liver Disease, 2011, 15, 2, 423

    CrossRef

  14. 14
    Giuseppe Cabibbo, Marco Enea, Massimo Attanasio, Jordi Bruix, Antonio Craxì, Calogero Cammà, A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma, Hepatology, 2010, 51, 4
  15. 15
    Jia Liu, Thomas Mittendorf, J.-Matthias von der Schulenburg, A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia, Cancer Investigation, 2010, 28, 3, 312

    CrossRef

  16. You have free access to this content16
    Chapter 4: Chemotherapy and radiotherapy, Hepatology Research, 2010, 40,
  17. 17
    Chiun Hsu, Ying-Chun Shen, Chia-Chi Cheng, Fu-Chang Hu, Ann-Lii Cheng, Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design, Contemporary Clinical Trials, 2010, 31, 1, 55

    CrossRef

  18. 18
    Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber, Hepatocellular Carcinoma: Current Management, Current Problems in Surgery, 2010, 47, 1, 10

    CrossRef

  19. 19
    Adam C. Yopp, William R. Jarnagin, Randomized Clinical Trials in Hepatocellular Carcinoma, Surgical Oncology Clinics of North America, 2010, 19, 1, 151

    CrossRef

  20. 20
    Andrew X. Zhu, Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?, Annals of Surgical Oncology, 2010, 17, 5, 1247

    CrossRef

  21. 21
    Arun AZAD, Fiona CHIONH, Jonathan CEBON, Targeted agents for the systemic treatment of advanced hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2009, 5, 2
  22. 22
    Hans Christian Spangenberg, Robert Thimme, Hubert E. Blum, Targeted therapy for hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 2009, 6, 7, 423

    CrossRef

  23. 23
    Anna K NOWAK, Jonathan CEBON, Carol HARGREAVES, Haryana DHILLON, Michael FINDLAY, Val GEBSKI, Martin R STOCKLER, Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2008, 4, 1
  24. 24
    Jin Lü, Xiufeng Cao, Dosimetry for 125I radioactive seed implantation therapy for hepatocellular carcinoma, Journal of Nanjing Medical University, 2008, 22, 5, 269

    CrossRef

  25. 25
    Ryota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Masao Omata, Hepatocellular carcinoma in viral hepatitis: Improving standard therapy, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1137

    CrossRef

  26. 26
    Robert J. Lewandowski, Joshua Tepper, Dingxin Wang, Saad Ibrahim, Frank H. Miller, Laura Kulik, Mary Mulcahy, Robert K. Ryu, Kent Sato, Andrew C. Larson, Riad Salem, Reed A. Omary, MR Imaging Perfusion Mismatch: A Technique to Verify Successful Targeting of Liver Tumors during Transcatheter Arterial Chemoembolization, Journal of Vascular and Interventional Radiology, 2008, 19, 5, 698

    CrossRef

  27. 27
    Josep M. Llovet, Jordi Bruix, Novel advancements in the management of hepatocellular carcinoma in 2008, Journal of Hepatology, 2008, 48, S20

    CrossRef

  28. 28
    D. Dasgupta, A. B. Smith, W. Hamilton-Burke, K. R. Prasad, G. J. Toogood, G. Velikova, J. P. A. Lodge, Quality of life after liver resection for hepatobiliary malignancies, British Journal of Surgery, 2008, 95, 7
  29. 29
    Khee Chee Soo, Role of comprehensive cancer centres during economic and disease transition: National Cancer Centre, Singapore—a case study, The Lancet Oncology, 2008, 9, 8, 796

    CrossRef

  30. 30
    Patricia Roxburgh, T. R. Jeffry Evans, Systemic therapy of hepatocellular carcinoma: Are we making progress?, Advances in Therapy, 2008, 25, 11, 1089

    CrossRef

  31. 31
    Robert J. Lewandowski, Dingxin Wang, James Gehl, Bassel Atassi, Robert K. Ryu, Kent Sato, Albert A. Nemcek, Frank H. Miller, Mary F. Mulcahy, Laura Kulik, Andrew C. Larson, Riad Salem, Reed A. Omary, A Comparison of Chemoembolization Endpoints Using Angiographic versus Transcatheter Intraarterial Perfusion/MR Imaging Monitoring, Journal of Vascular and Interventional Radiology, 2007, 18, 10, 1249

    CrossRef

  32. 32
    Anthony Soon-Whatt Goh, Alexander Yaw-Fui Chung, Richard Houa-Gong Lo, Te-Neng Lau, Sidney Wing-Kwong Yu, May Chng, Somanesan Satchithanantham, Susan Li-Er Loong, David Chee-Eng Ng, Beng-Choo Lim, Stephen Connor, Pierce Kah-Hoe Chow, A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device—a first-in-man study, International Journal of Radiation Oncology*Biology*Physics, 2007, 67, 3, 786

    CrossRef

  33. 33
    Toshimi Kaido, Characteristics and Quality of Randomized Controlled Trials in the Treatment of Hepatocellular Carcinoma, Digestive Diseases and Sciences, 2007, 52, 4, 1108

    CrossRef

  34. 34
    Silvia Gómez Senent, César Gómez Raposo, José María Segura Cabral, Guía para el diagnóstico, estadificación y tratamiento del hepatocarcinoma, Medicina Clínica, 2007, 128, 19, 741

    CrossRef

  35. 35
    Philippe Rougier, Emmanuel Mitry, Jean-Claude Barbare, Julien Taieb, Hepatocellular Carcinoma (HCC): An Update, Seminars in Oncology, 2007, 34, S12

    CrossRef

  36. 36
    Robert G. Gish, Garrett Hisatake, Improving clinical trial design for hepatocellular carcinoma treatments, Oncology Reviews, 2007, 1, 1, 45

    CrossRef

  37. 37
    Katharina Schmid, Xiaowei Wang, Andrea Haitel, Wolfgang Sieghart, Markus Peck-Radosavljevic, Martin Bodingbauer, Susanne Rasoul-Rockenschaub, Fritz Wrba, KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study, Virchows Archiv, 2007, 450, 2, 143

    CrossRef

  38. 38
    Ana Carolina del Pozo, Patricia López, Management of Hepatocellular Carcinoma, Clinics in Liver Disease, 2007, 11, 2, 305

    CrossRef

  39. 39
    Ying Chun Shen, Chiun Hsu, Ann Lii Cheng, Molecular targeted therapy for advanced hepatocellular carcinoma, Targeted Oncology, 2007, 2, 4, 199

    CrossRef

  40. 40
    Yan-Bin Wang, Min-Hua Chen, Kun Yan, Wei Yang, Ying Dai, Shan-Shan Yin, Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone, Quality of Life Research, 2007, 16, 3, 389

    CrossRef

  41. 41
    Steven R. Alberts, Gregory J. Gores, George P. Kim, Lewis R. Roberts, Michael L. Kendrick, Charles B. Rosen, Suresh T. Chari, James A. Martenson, Treatment Options for Hepatobiliary and Pancreatic Cancer, Mayo Clinic Proceedings, 2007, 82, 5, 628

    CrossRef

  42. 42
    Pierre Chan, Ching Lai, Man Yuen, Gastrointestinal Oncology, 2007,

    CrossRef

  43. 43
    Christian Müller, Hepatocellular carcinoma – Rising incidence, changing therapeutic strategies, Wiener Medizinische Wochenschrift, 2006, 156, 13-14, 404

    CrossRef

  44. 44
    J Cebon, Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide, British Journal of Cancer, 2006, 95, 7, 853

    CrossRef

  45. 45
    P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET, Systematic review: evidence-based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials, Alimentary Pharmacology & Therapeutics, 2006, 23, 11
  46. 46
    Michel Doffoël, Ahmed Ananna, Traitement palliatif du carcinome hépatocellulaire, Gastroentérologie Clinique et Biologique, 2006, 30, 6-7, 887

    CrossRef

  47. 47
    Alejandro Forner, Amelia J. Hessheimer, M. Isabel Real, Jordi Bruix, Treatment of hepatocellular carcinoma, Critical Reviews in Oncology/Hematology, 2006, 60, 2, 89

    CrossRef

  48. 48
    Mary F. Mulcahy, Management of hepatocellular cancer, Current Treatment Options in Oncology, 2005, 6, 5, 423

    CrossRef

  49. 49
    Jordi Bruix, Morris Sherman, Management of hepatocellular carcinoma, Hepatology, 2005, 42, 5
  50. 50
    Pierce K. Chow, Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma, Cancer Treatment Reviews, 2005, 31, 6, 491

    CrossRef

  51. 51
    Michel Beaugrand, Jean-Claude Trinchet, Traitement non chirurgical du carcinome hépatocellulaire. Une vision d'ensemble, Cancer/Radiothérapie, 2005, 9, 6-7, 464

    CrossRef

  52. 52
    Hubert E. Blum, Treatment of hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, 2005, 19, 1, 129

    CrossRef

  53. 53
    Anna K. Nowak, Martin R. Stockler, Pierce K. H. Chow, Michael Findlay, Use of tamoxifen in advanced-stage hepatocellular carcinoma, Cancer, 2005, 103, 7
  54. 54
    Jong Doo Lee, Mijin Yun, Jae Myun Lee, Youjeong Choi, Youn-Hee Choi, Ji Su Kim, Se Jong Kim, Kyung Sik Kim, Woo Ick Yang, Young Nyun Park, Kwang-Hyub Han, Woo Jung Lee, Naechun Yoo, Sang Moo Lim, Jeon Han Park, Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography, European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31, 12, 1621

    CrossRef

  55. 55
    Youliang Wang, Fang Cui, Yaxin Lv, Cuiling Li, Xiaoling Xu, Chuxia Deng, Dongping Wang, Yansong Sun, Gengxi Hu, Zhenwei Lang, Cuifen Huang, Xiao Yang, HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice, Hepatology, 2004, 39, 2
  56. 56
    Luis J. Lopez, Jorge A. Marrero, Hepatocellular carcinoma, Current Opinion in Gastroenterology, 2004, 20, 3, 248

    CrossRef

  57. 57
    Laurie Blendis, Morris Sherman, Hepatocellular Carcinoma, American Journal of Cancer, 2004, 3, 6, 349

    CrossRef

  58. 58
    Mike Cusnir, Yehuda Z. Patt, Novel Systemic Therapy Options for Hepatocellular Carcinoma, The Cancer Journal, 2004, 10, 2, 97

    CrossRef

  59. 59
    Daniel H Palmer, Syed A Hussain, Philip J Johnson, Systemic therapies for hepatocellular carcinoma, Expert Opinion on Investigational Drugs, 2004, 13, 12, 1555

    CrossRef

  60. 60
    Anna K Nowak, Pierce K.H Chow, Michael Findlay, Systemic therapy for advanced hepatocellular carcinoma: a review, European Journal of Cancer, 2004, 40, 10, 1474

    CrossRef

  61. 61
    Adam Holownia, Jan J Braszko, Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4, Biochemical Pharmacology, 2004, 67, 6, 1057

    CrossRef

  62. 62
    Edgar V Mocanu, Robert F Harrison, Tamoxifen in gynaecology, Reviews in Gynaecological Practice, 2004, 4, 1, 37

    CrossRef

  63. 63
    Jonathan D. Schwartz, Andreas S. Beutler, Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials???II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma, Anti-Cancer Drugs, 2004, 15, 5, 439

    CrossRef

  64. 64
    I. Hourmand-Ollivier, L. Chiche, Traitement du carcinome hépatocellulaire sur cirrhose, Journal de Chirurgie, 2004, 141, 2, 71

    CrossRef

  65. 65
    Beatrice Gerard, Harry Bleiberg, Treatment of hepatocarcinoma, Current Oncology Reports, 2004, 6, 3, 184

    CrossRef

  66. 66
    Josep M Llovet, Andrew Burroughs, Jordi Bruix, Hepatocellular carcinoma, The Lancet, 2003, 362, 9399, 1907

    CrossRef

  67. 67
    Tamar Hayon, Lena Atlas, Etti Levy, Alexander Dvilansky, Ofer Shpilberg, Ilana Nathan, Multifactorial activities of nonsteroidal antiestrogens against leukemia, Cancer Detection and Prevention, 2003, 27, 5, 389

    CrossRef

  68. 68
    John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan, Pharmacotherapy of hepatocellular carcinoma, Expert Opinion on Pharmacotherapy, 2003, 4, 12, 2175

    CrossRef

  69. 69
    References,
  70. 70
    Anna K Nowak, Michael Findlay, Gordana Culjak, Martin R Stockler, Tamoxifen for hepatocellular carcinoma, The Cochrane Library,